Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Achaogen Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Achaogen Inc. - Product Pipeline Review - 2014', provides an overview of the Achaogen Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Achaogen Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Achaogen Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Achaogen Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Achaogen Inc.'s pipeline products Reasons to buy - Evaluate Achaogen Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Achaogen Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Achaogen Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Achaogen Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Achaogen Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Achaogen Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Achaogen Inc. Snapshot 5 Achaogen Inc. Overview 5 Key Information 5 Key Facts 5 Achaogen Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Achaogen Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Achaogen Inc. - Pipeline Products Glance 10 Achaogen Inc. - Late Stage Pipeline Products 10 Phase III Products/Combination Treatment Modalities 10 Achaogen Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Achaogen Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Achaogen Inc. - Drug Profiles 14 plazomicin 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Monoclonal Antibodies for Pseudomonas aeruginosa Infections 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Small Molecule Inhibiting LpxC For Pseudomonas Aeruginosa Infections 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Small Molecules for Bacterial Infections 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Small Molecules for Gram-Negative Bacterial Infections 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Small Molecules to Inhibit Metabolic Enzymes for Gram-Negative Bacterial Infections 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Achaogen Inc. - Pipeline Analysis 21 Achaogen Inc. - Pipeline Products by Target 21 Achaogen Inc. - Pipeline Products by Route of Administration 22 Achaogen Inc. - Pipeline Products by Molecule Type 23 Achaogen Inc. - Pipeline Products by Mechanism of Action 24 Achaogen Inc. - Recent Pipeline Updates 25 Achaogen Inc. - Dormant Projects 26 Achaogen Inc. - Discontinued Pipeline Products 27 Discontinued Pipeline Product Profiles 27 ACHN-975 27 Achaogen Inc. - Locations And Subsidiaries 28 Head Office 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30
List of Tables Achaogen Inc., Key Information 5 Achaogen Inc., Key Facts 5 Achaogen Inc. - Pipeline by Indication, 2014 7 Achaogen Inc. - Pipeline by Stage of Development, 2014 8 Achaogen Inc. - Monotherapy Products in Pipeline, 2014 9 Achaogen Inc. - Phase III, 2014 10 Achaogen Inc. - Phase II, 2014 11 Achaogen Inc. - Preclinical, 2014 12 Achaogen Inc. - Discovery, 2014 13 Achaogen Inc. - Pipeline by Target, 2014 21 Achaogen Inc. - Pipeline by Route of Administration, 2014 22 Achaogen Inc. - Pipeline by Molecule Type, 2014 23 Achaogen Inc. - Pipeline Products by Mechanism of Action, 2014 24 Achaogen Inc. - Recent Pipeline Updates, 2014 25 Achaogen Inc. - Dormant Developmental Projects,2014 26 Achaogen Inc. - Discontinued Pipeline Products, 2014 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.